-
Profit from MSCI – the backbone of financeAs an index provider, MSCI is a key part of the global financial system. Its shares look cheap
-
Should you join the rush for venture-capital trusts?Opinion Investors hoping to buy into venture-capital trusts before the end of the tax year may need to move quickly, says David Prosser
Opinion -
Barings Emerging Europe trust bounces back from Russia woesBarings Emerging Europe trust has added the Middle East and Africa to its mandate, delivering a strong recovery, says Max King
-
Are activists coming for your investment trust?How can you tell if your investment trust might be targeted by activists? We look at the warning signs and how to know when a takeover might not be so bad
-
Saba Capital is doing wonders for shareholder democracyActivist hedge fund Saba Capital isn’t popular, but it has ignited a new age of shareholder engagement, says Rupert Hargreaves
-
Exciting opportunities in biotechBiotech firms should profit from the ‘patent cliff’, which will force big pharmaceutical companies to innovate or make acquisitions
-
Why small investment trusts can make great investmentsOften overlooked by larger institutions, smaller investment trusts can offer investors access to high-growth micro companies. We explore why they’re worth considering.
-
Edinburgh Worldwide shareholders reject Saba proposalsToday’s requisitioned general meeting of Edinburgh Worldwide shareholders has ended in another defeat for activist investor Saba Capital management
-
Tap income and capital growth in markets worldwideOpinion Three investment trusts with potential for capital growth, selected by Adam Norris, co-portfolio manager of the CT Global Managed Portfolio Trust
Opinion
